Notes![what is notes.io? What is notes.io?](/theme/images/whatisnotesio.png)
![]() ![]() Notes - notes.io |
99; 95% CI 0.99-1.00), and number of prescribed classes of antihypertensive medications (OR 0.81; 95% CI 0.72-0.92).
Nearly a third of stroke survivors in this Ghanaian sample were on multivitamin supplementation, with select socio-clinical factors being linked to this practice. Future studies should examine how/if this practice is interfering with optimal stroke outcomes.
Nearly a third of stroke survivors in this Ghanaian sample were on multivitamin supplementation, with select socio-clinical factors being linked to this practice. Future studies should examine how/if this practice is interfering with optimal stroke outcomes.
Stroke patients are frequently transported to a comprehensive stroke center for treatment, either from a regional hospital via interhospital transfer or from the field via direct-from-scene transfer, by air or ground transportation. We sought to determine whether air or ground transport was faster in both transfer circumstances.
A retrospective study of patients transferred to a single comprehensive stroke center for stroke treatment was conducted. EMS and medical records were used to evaluate the time and distance of transfer and functional outcome.
Of the 205 transfers, 47 were interhospital transfers by air (22.9%), 68 were interhospital transfers by ground (33.2%), 40 were scene transfers by air (19.5%), and 50 were scene transfers by ground (24.4%). Ground transfers had shorter alarm to EMS departure times (30 min. vs 40 min.; p<0.0001). Air transfers had shorter EMS departure to arrival times when normalized by transfer distance indicating a faster travel velocity. Interhospital transfers by air were predicted to be faster than ground over 40 miles, and scene transfers by air were predicted to be faster than ground over 28 miles. Transfer mode had no significant effect on functional outcome when controlling for tPA, thrombectomy, and NIH Stroke Scale in this small study.
Transfer efficiency for stroke patients depends on logistics prior to EMS arrival as well as the speed of travel. While air transport clearly results in faster travel velocity, total interhospital transfer times are faster for air transportation only when traveling more than 40 miles.
Transfer efficiency for stroke patients depends on logistics prior to EMS arrival as well as the speed of travel. While air transport clearly results in faster travel velocity, total interhospital transfer times are faster for air transportation only when traveling more than 40 miles.
STK11 is an important tumour suppressor gene reported to confer immunotherapy resistance in non-small-cell lung cancers (NSCLC) especially in the presence of KRAS co-alterations.
This study analysed 4446 patients for whom next-generation sequencing of tissue and/or circulating tumour DNA (ctDNA) had been performed.
Overall, 60 of 4446 tumours (1.35%) harboured STK11 alterations. Epacadostat STK11 alterations were associated with shorter median time to progression and overall survival (OS) across cancers from diagnosis 6.4 months (5.1-7.9) versus 12 months (11.7-12.3; p=0.001); and 20.5 (17.4-23.5) versus 29.1 (26.9-31.3; p=0.03), respectively (pan-cancer). Pan-cancers, the median progression-free survival (PFS; 95% CI) for first-line therapy (regardless of treatment type) for those with co-altered STK11 and KRAS (N=27; versus STK11-altered and KRAS wild type [N=33]), was significantly shorter (3 [1.3-4.7] versus 10 [4.9-15.7] months, p<0.0005, p multivariate, 0.06); the median OS also was also shorter (p multivain NSCLC. Pan-cancer patients with co-altered STK11/KRAS did worse, regardless of treatment type.
Although osimertinib overcomes the T790M mutation acquired after traditional epidermal growth factor receptor (EGFR) gene tyrosine kinase inhibitor (TKI) treatment, resistance to osimertinib eventually occurs. We explored resistance mechanisms of second-line osimertinib and their clinical implications by comparing next-generation sequencing (NGS) results before and after resistance acquisition.
We enrolled 34 patients with advanced EGFR-mutant adenocarcinoma whose biopsied tumour tissues were subjected to targeted NGS at the time of progression on osimertinib. For comparison, NGS was also performed on archived tumour tissues from each patient excised before osimertinib initiation.
The tumours of three patients' were observed to have transformed to small-cell carcinoma and those of two patients to squamous cell carcinoma. Among the remaining 29 patients, T790M mutations were maintained in seven patients (24.1%), including four patients (13.8%) acquiring C797S mutations and one with MET amplification. Among the 22 patients (75.9%) with T790M loss, a variety of novel mutations were identified, including KRAS mutations, PIK3CA mutations, and RET fusion, but MET amplifications (n=4, 18.2%) were most frequently identified variations. Progression-free survival (PFS) on osimertinib was shorter among patients with T790M loss than among those who maintained T790M (5.36 versus 13.81 months, p=0.009), and MET-amplified patients were found to have much worse PFS among patients with T790M loss (2.10 versus 6.35 months, p=0.01).
Loss of the T790M mutation was associated with early resistance to osimertinib, and this was exacerbated by MET amplification. Further work is needed to fully understand the implications of each resistance mechanism.
Loss of the T790M mutation was associated with early resistance to osimertinib, and this was exacerbated by MET amplification. Further work is needed to fully understand the implications of each resistance mechanism.
Previous studies on oxaliplatin and fluoropyrimidines as adjuvant therapy in older patients with stage III colon cancer (CC) produced conflicting results.
We assessed the impact of age on time to tumour recurrence (TTR), disease-free survival (DFS), cancer-specific survival (CSS), and overall survival (OS) in 2360 patients with stage III CC (1667 aged <70 years and 693≥70 years) randomised to receive 3 or 6 months of FOLFOX or CAPOX within the frame of the phase III, TOSCA study.
Older patients compared with younger ones presented more frequently an Eastern Cooperative Oncology Group performance status equal to 1 (10.5% vs 3.3%, p<0.001), a greater number of right-sided tumours (40.9% vs 26.6%, p<0.001), and were at higher clinical risk (37.2% vs 33.2%, p=0.062). The treatments were almost identical in the two cohorts (p=0.965). We found a greater proportion of dose reductions (46.7% vs 41.4%, p=0.018), treatment interruptions (26.1% vs 19.3%, p<0.001)and a higher proportion of recurrences (24.2% vs 20.3%, p=0.033) in the older patients. The multivariable analysis of the TTR did not indicate a statistically significant effect of age (hazard ratio [HR] 1.19; 95% confidence interval [CI] 0.98-1.44; p=0.082). The HR comparing older with younger patients was 1.34 (95% CI 1.12-1.59; p=0.001) for DFS, 1.58 (95% CI 1.26-1.99; p<0.001) for OS, and 1.28 (95% CI 0.96-1.70; p=0.089) for CSS.
Worse prognostic factors and reduced treatment compliance have a negative impact on the efficacy of oxaliplatin-based adjuvant therapy in older patients.
Worse prognostic factors and reduced treatment compliance have a negative impact on the efficacy of oxaliplatin-based adjuvant therapy in older patients.Speaker recognition is a task of identifying persons from their voices. Recently, deep learning has dramatically revolutionized speaker recognition. However, there is lack of comprehensive reviews on the exciting progress. In this paper, we review several major subtasks of speaker recognition, including speaker verification, identification, diarization, and robust speaker recognition, with a focus on deep-learning-based methods. Because the major advantage of deep learning over conventional methods is its representation ability, which is able to produce highly abstract embedding features from utterances, we first pay close attention to deep-learning-based speaker feature extraction, including the inputs, network structures, temporal pooling strategies, and objective functions respectively, which are the fundamental components of many speaker recognition subtasks. Then, we make an overview of speaker diarization, with an emphasis of recent supervised, end-to-end, and online diarization. Finally, we survey robust speaker recognition from the perspectives of domain adaptation and speech enhancement, which are two major approaches of dealing with domain mismatch and noise problems. Popular and recently released corpora are listed at the end of the paper.Dynamically impacting systems are characterised with inherent instability and complex non-linear phenomena which makes it practically difficult to predict the steady state response of the system at transient periods. This study investigates the ability of a data driven machine learning method using Long Short-Term Memory networks to learn the complex nonlinearity associated with co-existing impact responses from limited transient data. A one-degree-of-freedom impact oscillator has been used to represent the bit-rock interaction for percussive drilling. Simulated data results show velocity measurements to contribute most to predicting steady state responses from transient dynamics with most of the network models reaching an accuracy of over 95%. Limitations to practically measurable variables in dynamic systems warranted the development of a feature based network model for impact motion classification. Experimental data from a two-degrees-of-freedom impacting system representing percussive bit penetration has been used to demonstrate the effectiveness of this method. The study thus provides a precise and less computational means of detecting and avoiding underperforming impact modes in percussive drilling.This paper presents a neural system to deal with multi-label classification problems that might involve sparse features. The architecture of this model involves three sequential blocks with well-defined functions. The first block consists of a multilayered feed-forward structure that extracts hidden features, thus reducing the problem dimensionality. This block is useful when dealing with sparse problems. The second block consists of a Long-term Cognitive Network-based model that operates on features extracted by the first block. The activation rule of this recurrent neural network is modified to prevent the vanishing of the input signal during the recurrent inference process. The modified activation rule combines the neurons' state in the previous abstract layer (iteration) with the initial state. Moreover, we add a bias component to shift the transfer functions as needed to obtain good approximations. Finally, the third block consists of an output layer that adapts the second block's outputs to the label space. We propose a backpropagation learning algorithm that uses a squared hinge loss function to maximize the margins between labels to train this network. The results show that our model outperforms the state-of-the-art algorithms in most datasets.Although neural models have performed impressively well on various tasks such as image recognition and question answering, their reasoning ability has been measured in only few studies. In this work, we focus on spatial reasoning and explore the spatial understanding of neural models. First, we describe the following two spatial reasoning IQ tests rotation and shape composition. Using well-defined rules, we constructed datasets that consist of various complexity levels. We designed a variety of experiments in terms of generalization, and evaluated six different baseline models on the newly generated datasets. We provide an analysis of the results and factors that affect the generalization abilities of models. Also, we analyze how neural models solve spatial reasoning tests with visual aids. We hope that our work can encourage further research into human-level spatial reasoning and provide a new direction for future work.
My Website: https://www.selleckchem.com/products/epacadostat-incb024360.html
![]() |
Notes is a web-based application for online taking notes. You can take your notes and share with others people. If you like taking long notes, notes.io is designed for you. To date, over 8,000,000,000+ notes created and continuing...
With notes.io;
- * You can take a note from anywhere and any device with internet connection.
- * You can share the notes in social platforms (YouTube, Facebook, Twitter, instagram etc.).
- * You can quickly share your contents without website, blog and e-mail.
- * You don't need to create any Account to share a note. As you wish you can use quick, easy and best shortened notes with sms, websites, e-mail, or messaging services (WhatsApp, iMessage, Telegram, Signal).
- * Notes.io has fabulous infrastructure design for a short link and allows you to share the note as an easy and understandable link.
Fast: Notes.io is built for speed and performance. You can take a notes quickly and browse your archive.
Easy: Notes.io doesn’t require installation. Just write and share note!
Short: Notes.io’s url just 8 character. You’ll get shorten link of your note when you want to share. (Ex: notes.io/q )
Free: Notes.io works for 14 years and has been free since the day it was started.
You immediately create your first note and start sharing with the ones you wish. If you want to contact us, you can use the following communication channels;
Email: [email protected]
Twitter: http://twitter.com/notesio
Instagram: http://instagram.com/notes.io
Facebook: http://facebook.com/notesio
Regards;
Notes.io Team